市場調查報告書
商品編碼
1379067
2023-2028 年按技術、細胞類型、產品、應用、最終用途和地區分類的細胞分離市場報告Cell Isolation Market Report by Technique, Cell Type, Product, Application, End Use, and Region 2023-2028 |
2022年全球細胞分離市場規模達到119億美元。展望未來, IMARC Group預計到2028年市場規模將達到285億美元,2022-2028年複合年成長率(CAGR)為15.7%。對再生醫學和細胞療法的需求不斷成長、對高效分離技術的需求、慢性病的激增以及對生物技術和生命科學的投資不斷增加是促進市場成長的因素。
細胞分離是生命科學領域的基本技術,涉及從複雜的生物樣本中分離特定的細胞群。該過程的運作原理是為各種下游應用獲得純細胞子集。它從樣本收集開始,然後進行組織解離以獲得單細胞。然後根據不同的特徵(如大小、表面標記或密度)分離這些細胞。細胞分離的優點是多方面的。它能夠精確分析細胞行為、基因表現和蛋白質功能,有助於疾病研究和藥物開發的進步。該技術可應用於癌症研究、免疫學和再生醫學等領域。細胞分離的方法有多種,包括磁激活細胞分選 (MACS)、螢光激活細胞分選 (FACS) 和密度梯度離心。
全球細胞分離市場受到再生醫學領域不斷擴大以及對高效細胞分離技術不斷成長的需求的影響。此外,慢性病盛行率的上升需要先進的細胞療法,從而促進市場成長。同時,生物技術和生命科學領域的資金和投資的增加推動了研發活動,進一步推動了市場的發展。此外,對個人化醫療的興趣日益高漲,加大了對精確細胞分離方法的需求,從而促進了市場的成長。除此之外,對癌症研究的日益關注和對標靶治療的需求正在促進市場成長。其他因素,例如人口老化加劇以及學術機構與產業參與者之間的合作激增,也有利於市場成長。
拓展再生醫學領域
全球細胞分離市場的成長與新興的再生醫學領域密切相關。再生醫學強調利用細胞的潛力來恢復受損的組織和器官,徹底改變醫療模式。隨著研究人員深入研究再生療法,精確、高效的細胞分離技術的必要性變得顯而易見。高純度分離特定細胞類型對於確保再生程序的成功至關重要。這種需求推動了尖端細胞分離技術的開發和採用,推動市場擴張。
慢性病盛行率上升
慢性病盛行率的不斷上升引發了對先進細胞療法的迫切需求,從而引發了細胞分離市場的顯著成長。心血管疾病、糖尿病和神經退化性疾病等慢性疾病為全球醫療保健系統帶來了巨大挑戰。基於細胞的療法透過提供再生和個人化治療方法在應對這些挑戰方面具有巨大的前景。為了發揮此類療法的潛力,分離存活且功能完整的細胞至關重要。這勢在必行,導致加強研發力度,創新高效的細胞分離方法,滿足細胞治療的多樣化需求,塑造市場軌跡。
生物技術和生命科學領域的融資和投資
在生物技術和生命科學領域強勁的資金和投資的推動下,細胞分離市場呈現上升趨勢。政府、私人投資者和創投家認知到細胞分離技術突破在疾病治療和藥物發現等各種應用中的變革潛力。因此,大量的財政支持被投入到旨在完善和創新細胞分離技術的研究工作中。這些資金的湧入不僅推動了新方法的開發,而且促進了先進細胞分離產品的商業化和可及性。金融投資和科學探索之間的協同作用推動市場向前發展,使其處於醫療和技術進步的前沿。
IMARC Group提供了全球細胞分離市場報告各細分市場主要趨勢的分析,以及 2023-2028 年全球、區域和國家層面的預測。我們的報告根據技術、細胞類型、產品、應用和最終用途對市場進行了分類。
離心
表面標記
濾
離心機主導市場
該報告根據該技術對市場進行了詳細的細分和分析。這包括離心、表面標記和過濾。根據該報告,離心法佔最大部分。
離心細分市場的成長受到關鍵因素的支撐,包括人們對離心技術所提供的多功能性的認知不斷增強,例如分離從血液成分到亞細胞細胞器的多種細胞類型。此外,離心機技術的不斷進步帶來了更高的處理速度和更高的分離效率,有助於其持續採用。此外,離心方法的可靠性和簡單性使其可供廣泛的使用者使用,包括研究人員和臨床醫生。此外,離心與各種樣品大小和體積的兼容性提供了靈活性,滿足不同的實驗需求。與此一致的是,它與血液、組織和細胞培養等各種樣本源的兼容性,使離心成為細胞分離工作流程中的通用且必不可少的技術,推動其在更廣泛的市場格局中的細分市場成長。
人體細胞
動物細胞
動物細胞在市場上佔有最大佔有率
報告中還根據細胞類型提供了詳細的市場細分和分析。這包括人類細胞和動物細胞。根據該報告,動物細胞佔最大部分。
動物細胞分離領域的成長得益於動物細胞在生物醫學研究和藥物開發中越來越多的應用。與此一致的是,生物製藥領域的不斷擴大依賴於動物細胞培養進行生產,這加劇了對有效分離方法的需求。此外,再生醫學的興起推動了對基於動物細胞的療法的探索,需要高品質的分離過程。此外,慢性疾病的激增需要使用動物細胞進行先進的疾病建模,進一步推動該領域的成長。細胞分離方法的技術進步滿足了分離動物細胞的複雜要求,促進了市場擴張。學術機構和產業參與者之間的合作促進了知識交流,為該領域的創新解決方案做出了貢獻。
耗材
試劑、試劑盒、培養基及血清
珠
免洗用品
儀器
離心機
流式細胞儀
過濾系統
磁激活細胞分離器系統
消耗品主導市場
該報告根據產品提供了詳細的市場細分和分析。這包括消耗品(試劑、試劑盒、培養基和血清、珠子和一次性用品)和儀器(離心機、流式細胞儀、過濾系統和磁激活細胞分離系統)。根據該報告,消耗品佔最大部分。
由於細胞療法和再生醫學的持續採用,細胞分離市場的消耗品領域正在經歷大幅成長,這導致對細胞分離過程中使用的消耗品的需求增加。隨著研究人員和臨床醫生努力挖掘細胞療法的潛力,對試劑、試劑盒和一次性用品等可靠有效的消耗品的需求變得至關重要。此外,慢性病盛行率的上升加劇了對精準醫療和個人化治療的關注,需要特定的耗材來分離目標細胞群。此外,耗材技術的進步,包括改進的標記和標記劑,提高了細胞分離程序的準確性和效率。此外,研究機構和耗材製造商之間的合作推動了創新,從而開發出適合不同研究需求的專用產品。
生物分子分離
療法
幹細胞研究
癌症研究
組織再生
體外診斷
生物分子分離佔據最大市場佔有率
報告還提供了基於應用程式的詳細市場細分和分析。這包括生物分子分離、治療、幹細胞研究、癌症研究、組織再生和體外診斷。根據該報告,生物分子分離佔據了最大的部分。
生物分子分離領域的成長受到幾個關鍵因素的推動,例如蛋白質體學和基因組學研究領域的不斷擴大。此外,對個人化醫療的日益關注需要提取特定的生物分子用於診斷和治療目的。此外,製藥和生物技術產業越來越依賴生物分子分離來加速藥物發現和開發過程。技術進步,特別是自動化和微流體技術的進步,提高了分離方法的效率和可擴展性,進一步推動了市場成長。學術機構和產業參與者之間的合作促進了知識交流,從而產生了創新的隔離解決方案。此外,研究應用和生物製藥領域對生物分子的需求不斷成長,也為該領域的擴張增添了動力。
生物技術和生物製藥公司
醫院和診斷實驗室
研究實驗室和研究所
其他
研究實驗室和研究所在市場上佔有最大佔有率
報告還提供了基於最終用途的詳細市場細分和分析。這包括生物技術和生物製藥公司、醫院和診斷實驗室、研究實驗室和研究所等。根據該報告,研究實驗室和研究所代表了最大的部分。
研究實驗室和研究所部門的成長受到科學探索領域不斷擴大的支撐,這推動了對尖端技術的需求。此外,人們對醫療保健和生命科學進步的日益關注需要高效的細胞分離技術,這正在促進市場成長。除此之外,學術界和工業界之間的合作增強了研究能力,刺激了對高品質細胞分離工具的需求。據此,增加資金和贈款將資源引導至研究機構,促進對先進隔離方法的投資。此外,研究的動態性質需要多功能的解決方案,從而促進可客製化細胞分離產品的採用。此外,藥物發現和開發的不斷發展加劇了對精確實驗的穩健細胞分離的依賴。
北美洲
美國
加拿大
亞太
中國
日本
印度
韓國
澳洲
印尼
其他
歐洲
德國
法國
英國
義大利
西班牙
俄羅斯
其他
拉丁美洲
巴西
墨西哥
其他
中東和非洲
北美表現出明顯的主導地位,佔據最大的細胞分離市場佔有率
市場研究報告還對所有主要區域市場進行了全面分析,其中包括北美(美國和加拿大);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。報告稱,北美佔據最大的市場佔有率。
北美細胞分離市場的成長得益於該地區強大的醫療基礎設施和高額的研究支出。此外,糖尿病和心血管疾病等慢性疾病的流行推動了對基於細胞的精確療法的需求,從而刺激了有效分離方法的採用。與此一致的是,主要生物技術和製藥企業的存在,加上學術界和工業界之間強而有力的研究合作,促進了技術創新。此外,來自政府措施和私人投資的大量資金推動了研發工作,促進了市場的擴張。除此之外,北美對個人化醫療和再生療法的日益關注增強了精確細胞分離的重要性。此外,該地區的監管框架和嚴格的品質標準為創新細胞分離產品的商業化創造了有利的環境,推動北美在全球市場中發揮重要作用。
全球細胞分離市場的競爭格局以塑造產業動態的動態因素為標誌。密集的研發活動推動了持續創新,從而引入了尖端的細胞分離技術。市場參與者努力增強產品組合,提供適合各種細胞類型和應用的多樣化分離解決方案。學術界和工業界之間的夥伴關係促進協作進步,有助於技術突破。監管合規性和品質標準在這一領域仍然至關重要,影響著市場進入和擴張策略。不斷發展的情況也見證了對自動化和先進技術整合的日益重視,旨在提高分離效率和重現性。隨著不斷成長的醫療需求和科學進步,市場受到關注,競爭加劇,促使參與者透過產品功效、可靠性和多功能性實現差異化,同時努力滿足研究和醫療保健領域不斷變化的需求。
阿法拉伐公司
貝克頓迪金森公司
貝克曼庫爾特公司(丹納赫公司)
Bio-Rad 實驗室公司
通用電氣公司
默克公司
Miltenyi Biotec BV & Co. KG
pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG
羅氏控股公司
幹細胞科技公司
泰爾茂株式會社
賽默飛世爾科技公司
2023 年 5 月,貝克曼庫爾特推出了新型先進免疫分析儀 DxI 9000 Access。此分析儀每小時每平方公尺最多可進行 215 次測試(測試/小時/平方公尺)。
2023年5月,Becton Dickinson and Company宣布投資8,000萬美元在華雷斯城興建第三家工廠。
2023 年 2 月,阿法拉伐 AB 將擴大瑞典、義大利、中國和美國的熱交換器產能,作為增加投資計畫的一部分。為此,它決定投資 38 億瑞典克朗(3.6 億美元)用於熱交換器產能擴張計劃
The global cell isolation market size reached US$ 11.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 28.5 Billion by 2028, exhibiting a growth rate (CAGR) of 15.7% during 2022-2028. The escalating demand for regenerative medicine and cell-based therapies, the need for efficient isolation techniques, a surge in chronic diseases, and growing investments in biotechnology and life sciences are factors augmenting the market growth.
Cell isolation, a fundamental technique in the realm of life sciences, involves the separation of specific cell populations from complex biological samples. The process operates on the principle of obtaining pure cell subsets for various downstream applications. It begins with sample collection, followed by tissue dissociation to obtain single cells. These cells are then isolated based on distinct characteristics like size, surface markers, or density. The advantages of cell isolation are manifold. It enables precise analysis of cell behavior, gene expression, and protein function, contributing to advancements in disease research and drug development. This technique finds application in fields such as cancer research, immunology, and regenerative medicine. There are several methods of cell isolation, including magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and density gradient centrifugation.
The global cell isolation market is influenced by the expanding field of regenerative medicine and the escalating need for efficient cell isolation techniques. Moreover, the rising prevalence of chronic diseases necessitates advanced cell-based therapies, boosting market growth. In line with this, increasing funding and investments in biotechnology and life sciences sectors fuel research and development activities, further propelling the market. Furthermore, the surging interest in personalized medicine amplifies the requirement for precise cell isolation methods, which is augmenting the market growth. Apart from this, the growing focus on cancer research and the need for targeted therapies are facilitating the market growth. Other factors, such as the escalating aging population and surging collaborations between academic institutions and industry players, are favoring the market growth.
Expanding field of regenerative medicine
The growth of the global cell isolation market is intricately linked to the burgeoning field of regenerative medicine. Regenerative medicine emphasizes harnessing the potential of cells to restore damaged tissues and organs, revolutionizing medical treatment paradigms. As researchers delve deeper into regenerative therapies, the necessity for precise and efficient cell isolation techniques becomes evident. Isolation of specific cell types with high purity is imperative to ensure the success of regenerative procedures. This demand drives the development and adoption of cutting-edge cell isolation technologies, propelling market expansion.
Rising prevalence of chronic diseases
The escalating prevalence of chronic diseases has ignited a pressing need for advanced cell-based therapies, igniting significant growth in the cell isolation market. Chronic conditions such as cardiovascular diseases, diabetes, and neurodegenerative disorders pose substantial challenges to global healthcare systems. Cell-based therapies hold immense promise in addressing these challenges by offering regenerative and personalized treatment approaches. To harness the potential of such therapies, the isolation of viable and functionally intact cells is paramount. This imperative has led to intensified research and development efforts to innovate efficient cell isolation methods that cater to the diverse needs of cell-based treatments, shaping the trajectory of the market.
Funding and investments in biotechnology and life sciences sectors
The cell isolation market experiences an upward trajectory driven by robust funding and investments in the biotechnology and life sciences sectors. Governments, private investors, and venture capitalists recognize the transformative potential of breakthroughs in cell isolation techniques for various applications, including disease treatment and drug discovery. Consequently, substantial financial support is channeled into research endeavors aimed at refining and innovating cell isolation technologies. This influx of funds not only fuels the development of novel methodologies but also facilitates the commercialization and accessibility of advanced cell isolation products. The synergy between financial investments and scientific exploration propels the market forward, positioning it at the forefront of medical and technological advancement.
IMARC Group provides an analysis of the key trends in each segment of the global cell isolation market report, along with forecasts at the global, regional, and country levels for 2023-2028. Our report has categorized the market based on technique, cell type, product, application, and end use.
Centrifugation
Surface Marker
Filtration
Centrifugation dominates the market
The report has provided a detailed breakup and analysis of the market based on the technique. This includes centrifugation, surface marker, and filtration. According to the report, centrifugation represented the largest segment.
The growth of the centrifugation segment is underpinned by pivotal factors, including the growing awareness regarding the versatility offered by centrifugation techniques, such as isolating a wide range of cell types, from blood components to subcellular organelles. Moreover, the continuous advancements in centrifuge technology, leading to higher processing speeds and improved separation efficiency, contribute to its sustained adoption. Additionally, the established reliability and simplicity of centrifugation methods make them accessible to a broad spectrum of users, including researchers and clinicians. Furthermore, the compatibility of centrifugation with various sample sizes and volumes provides flexibility, catering to different experimental needs. In line with this, its compatibility with various sample sources, such as blood, tissues, and cell cultures, positions centrifugation as a versatile and essential technique in cell isolation workflows, driving its segment growth within the broader market landscape.
Human Cells
Animal Cells
Animal cells hold the largest share in the market
A detailed breakup and analysis of the market based on the cell type has also been provided in the report. This includes human cells and animal cells. According to the report, animal cells represented the largest segment.
The growth of the animal cell isolation segment is underpinned by the increasing application of animal cells in biomedical research and drug development. In line with this, the expanding field of biopharmaceuticals relies on animal cell cultures for production, intensifying the need for efficient separation methods. Additionally, the rise in regenerative medicine drives the exploration of animal cell-based therapies, necessitating high-quality isolation processes. Moreover, the surge in chronic diseases necessitates advanced disease modeling using animal cells, further propelling the segment's growth. Technological advancements in cell isolation methodologies cater to the intricate requirements of isolating animal cells, fostering market expansion. Collaborations between academic institutions and industry players facilitate knowledge exchange, contributing to innovative solutions in this segment.
Consumables
Reagents, Kits, Media and Sera
Beads
Disposables
Instruments
Centrifuges
Flow Cytometers
Filtration Systems
Magnetic-activated Cell Separator Systems
Consumables dominate the market
The report has provided a detailed breakup and analysis of the market based on the product. This includes consumables (reagents, kits, media and sera, beads, and disposables) and instruments (centrifuges, flow cytometers, filtration systems, and magnetic-activated cell separator systems). According to the report, consumables represented the largest segment.
The consumables segment in the cell isolation market is experiencing substantial growth due to the escalating adoption of cell-based therapies and regenerative medicine, which has led to an increased demand for consumable products used in cell isolation processes. As researchers and clinicians strive to harness the potential of cell therapies, the need for reliable and effective consumables such as reagents, kits, and disposables becomes paramount. Moreover, the rising prevalence of chronic diseases has amplified the focus on precision medicine and personalized treatments, necessitating specific consumables for isolating targeted cell populations. Additionally, advancements in consumable technologies, including improved labeling and tagging agents, have enhanced the accuracy and efficiency of cell isolation procedures. Furthermore, collaborations between research institutions and consumable manufacturers have driven innovation, leading to the development of specialized products tailored to diverse research needs.
Biomolecule Isolation
Therapeutics
Stem Cell Research
Cancer Research
Tissue Regeneration
In-Vitro Diagnostics
Biomolecule isolation holds the largest share in the market
A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes biomolecule isolation, therapeutics, stem cell research, cancer research, tissue regeneration, and in-vitro diagnostics. According to the report, biomolecule isolation represented the largest segment.
The growth of the biomolecule isolation segment is propelled by several pivotal factors, such as the expanding field of proteomics and genomics research. Additionally, the rising focus on personalized medicine necessitates the extraction of specific biomolecules for diagnostic and therapeutic purposes. Moreover, the pharmaceutical and biotechnology industries increasingly rely on biomolecule isolation to accelerate drug discovery and development processes. Technological advancements, particularly in automation and microfluidics, enhance the efficiency and scalability of isolation methods, further driving market growth. Collaborations between academic institutions and industry players facilitate knowledge exchange, leading to innovative isolation solutions. Furthermore, the growing demand for biomolecules in research applications and the biopharmaceutical sector adds impetus to the segment's expansion.
Biotechnology and Biopharmaceutical Companies
Hospitals and Diagnostic Laboratories
Research Laboratories and Institutes
Others
Research laboratories and institutes hold the largest share in the market
A detailed breakup and analysis of the market based on the end use has also been provided in the report. This includes biotechnology and biopharmaceutical companies, hospitals and diagnostic laboratories, research laboratories and institutes, and others. According to the report, research laboratories and institutes represented the largest segment.
The growth of the research laboratories and institutes segment is underpinned by the expanding landscape of scientific exploration, which has propelled the demand for cutting-edge technologies. Moreover, the escalating focus on advancements in healthcare and life sciences necessitates efficient cell isolation techniques, which is boosting market growth. Apart from this, collaborations between academia and industry amplify research capabilities, stimulating the need for high-quality cell isolation tools. In line with this, increasing funding and grants channel resources toward research institutions, facilitating investment in advanced isolation methodologies. Additionally, the dynamic nature of research demands versatile solutions, boosting the uptake of customizable cell isolation products. Furthermore, the continuous evolution of drug discovery and development intensifies the reliance on robust cell isolation for accurate experimentation.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest cell isolation market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America's growth in the cell isolation market is underpinned by the region's robust healthcare infrastructure and high research expenditure. Moreover, a prevalence of chronic diseases like diabetes and cardiovascular ailments drives the necessity for accurate cell-based therapies, spurring the adoption of efficient isolation methods. In line with this, the presence of major biotechnology and pharmaceutical players, coupled with strong research collaborations between academia and industry, fosters technological innovation. Furthermore, substantial funding from government initiatives and private investments fuels research and development endeavors, enhancing the market's expansion. Apart from this, an increasing focus on personalized medicine and regenerative therapies in North America amplifies the significance of precise cell isolation. Additionally, the region's regulatory framework and stringent quality standards create a conducive environment for the commercialization of innovative cell isolation products, propelling North America's prominent role in the global market.
The competitive landscape of the global cell isolation market is marked by dynamic factors that shape industry dynamics. Intense research and development activities drive continuous innovation, resulting in the introduction of cutting-edge cell isolation technologies. Market players strive to enhance product portfolios, offering a diverse range of isolation solutions catering to various cell types and applications. Partnerships between academia and industry foster collaborative advancement, contributing to technological breakthroughs. Regulatory compliance and quality standards remain pivotal in this landscape, influencing market entry and expansion strategies. The evolving landscape also witnesses an increasing emphasis on automation and integration of advanced techniques, aimed at improving isolation efficiency and reproducibility. As the market gains traction due to growing medical needs and scientific advancements, competition intensifies, propelling players to differentiate through product efficacy, reliability, and versatility while striving to address the ever-evolving demands of the research and healthcare sectors.
Alfa Laval AB
Becton Dickinson and Company
Beckman Coulter Inc. (Danaher Corporation)
Bio-Rad Laboratories Inc.
General Electric Company
Merck KGaA
Miltenyi Biotec B.V. & Co. KG
pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG
Roche Holding AG
STEMCELL Technologies Inc.
Terumo Corporation
Thermo Fisher Scientific Inc.
In May 2023, Beckman Coulter introduced a new advanced immunoassay analyser, DxI 9000 Access. The analyser has the capacity to conduct up to 215 tests per hour per square metre (tests/h/m²).
In May 2023, Becton Dickinson and Company announced to invest US$ 80 million in the construction of its third plant in Ciudad Juarez.
In February 2023, Alfa Laval AB is expanding production capacity for heat exchangers in Sweden, Italy, China and the US as part of an increased investment program. For this, it has decided to invest SEK 3.8 billion ($360 million) in a capacity expansion program for heat exchangers